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Common variable immune deficiency disorder (CVID) is the most clinically relevant cause
of antibody failure. It is a highly heterogeneous disease with different underlying etiologies.
CVID has been associated with a quantitative B cell defect, however, little is known
about the quality of B cells present. Here, we studied the naïve and antigen selected
B-cell receptor (BCR) repertoire in 33 CVID patients using next generation sequencing, to
investigate B cells quality. Analysis for each individual patient revealed whether they have
a defect in immune repertoire formation [V(D)J recombination] or specification (somatic
hypermutation, subclass distribution, or selection). The naïve BCR repertoire was normal
in most of the patients, although alterations in repertoire diversity and the junctions
were found in a limited number of patients indicating possible defects in early B-cell
development or V(D)J recombination in these patients. In contrast, major differences
were found in the antigen selected BCR repertoire. Here, most patients (15/17) showed
a reduced frequency of somatic hypermutation (SHM), changes in subclass distribution
and/or minor alterations in antigen selection. Together these data show that in our CVID
cohort only a small number of patients have a defect in formation of the naïve BCR
repertoire, whereas the clear majority of patients have disturbances in their antigen
selected repertoire, suggesting a defect in repertoire specification in the germinal centers
of these patients. This highlights that CVID patients not only have a quantitative B cell
defect, but that also the quality of, especially post germinal center B cells, is impaired.
Keywords: common variable immune deficiency disorder, B-cell receptor repertoire, repertoire formation,
repertoire specification, germinal center, somatic hypermutation
INTRODUCTION
Common variable immune deficiency disorder (CVID) is the most frequent, clinically relevant
antibody deficiency. The most prominent features of CVID include increased risk of (recurrent)
infections, low serum IgG in combination with low serum IgM and/or IgA and poor antigen specific
antibody responses. In addition, non-infection complications such as granulomas, auto-immunity
or malignancies are found in part of the patients (1). According to the ESID diagnostic criteria of
CVID, any defined cause of antibody deficiency must be excluded, leaving a highly heterogeneous
van Schouwenburg et al. B Cell Receptor Repertoire Analysis in CVID
patient group in terms of clinical features and underlying disease
etiologies. The majority of CVID cases is thought to be polygenic
in nature (2, 3), although monogenic defects have been described
in an increasing number of patients (4–6). CVID is associated
with a defect in B-cell development, but the affected stage differs
between patients (7).
B cells develop in the bone marrow, where they undergo
V(D)J recombination to produce a unique B-cell receptor (BCR).
In each precursor B cell, one variable (V) gene is combined
with one diversity (D) and one joining (J) gene to create the
immunoglobulin heavy chain (IGH) encoding gene. The high
number of combinations of V, D, and J genes together with the
addition of non-templated (N)-nucleotides and the deletion of
nucleotides in the junctional regions allows for the generation
of a great variety of BCRs. After successfully completing V(D)J
recombination on the IGH locus, and rearranging the light chain
(IGL) the formed BCR is tested for auto-reactivity and if needed
auto-reactive B-cells undergo receptor editing or apoptosis
while non-auto-reactive B-cells migrate to the periphery and
differentiate into naïve B-cells. The total set of BCRs of naïve B-
cells is referred to as the naïve BCR repertoire which is the result
of repertoire formation in the bone marrow.
In the periphery, naïve B cells become activated upon
antigen recognition. Upon B-T cell interaction, activated B cells
migrate to the dark zone of the germinal center (GC) where
they undergo rapid proliferation and somatic hyper mutation
(SHM). During SHM, mutations are introduced in the BCR
encoding genes allowing further specification of the receptor.
SHM is initiated by AID, which deaminates a cytosine into a
uracil (U) creating U lesions mainly in RGYW/WRCY motifs
(R = Purine, Y = pyrimidine, W = A or T) which can be
resolved via three main pathways. First, during error prone
base excision repair (BER) the U is removed and replaced by
error-prone translesion synthesis (TLS) polymerases leading to
transitions or transversions at C/G locations (8, 9). Second,
during error prone mismatch repair (MMR) the U and multiple
bases surrounding the mismatch are excised (10–12). Then,
the error prone polymerase pol eta fills the single stand gap,
preferentially making errors at AT locations (TW/WA motifs).
Finally, in absence of repair, the U is recognized as a T during
replication leading to transitions at G/C locations.
Subsequently, B cells migrate to the light zone of the GCwhere
they undergo antigen selection and class switch recombination
(CSR). During antigen selection, B cells with SHMs leading to
a BCR with increased affinity get selected for survival, while
cells with affinity decreasing mutations undergo apoptosis (13).
During CSR the constant domain of the BCR encoding gene is
replaced which changes the effector function of the antibodies
produced (13). The resulting set of BCR, developed upon
specification of the repertoire in the GC is defined as the antigen
selected repertoire.
In previous studies it has been shown that CVID patients
often have a quantitative defect in B cell development, however,
less is known about the quality of the developed B cells (7,
14, 15). We have previously analyzed the naïve BCR repertoire
in a cohort of 18 CVID patients, and found that the majority
of patients had a normal naïve BCR repertoire with respect
to gene segment usage, composition of the complementarity
determining region 3 (CDR3) and receptor diversity suggesting
normal repertoire formation (16). In contrast, Roskin et al.
recently reported alterations in VDJ reagerangement, CDR3
formation, diversity and SHM upon the analysis of the BCR
repertoire in CVID patients suggesting defects in repertoire
formation and specification in their cohort (17). To get a
more detailed view to which extent repertoire formation and
specification is affected in individual CVID patients, we now
studied both the naïve BCR repertoire and antigen selected BCR
repertoire on sorted or selected B-cells in a group of 33 CVID
patients using next generation sequencing (18). In contrast to
previous studies, we focus on deviations per patient to be able
to identify processes affected in individual patients instead of
comparing CVID patients as a group to controls. We performed
detailed analysis on all the parameters associated with auto-
immunity and parameters associated with repertoire formation
[i.e., V(D)J recombination] and specification (SHM, CSR, and
antigen selection). In parameters of the naïve repertoire, only
minor differences were observed in a minority of patients.
In contrast, our data showed major skewing in the antigen
selected repertoire including SHM frequencies and IGH subclass
distribution in the majority of CVID patients, in line with
defects in the GC. Together this suggest that repertoire formation
is intact in the majority of CVID patients, while repertoire
specification is impaired in the majority of patients.
MATERIALS AND METHODS
Healthy Donors and Patients
Peripheral blood samples were collected from 33 HCs and
33 CVID patients (age 6 −79 y). Patients were recruited
to the study “Primary Immune Deficiencies: immunological
and genetic background in relation to clinical complications”
(ErasmusMC METC MEC-2013-026/NL40331.078.12) or the
study “The genetic and functional characterization of patients
with Primary Immune Deficiencies, Infections and Inflammatory
conditions” (South Hampshire Research Ethics Committee,
12/SC/0044). The study was reviewed and approved by the
above-mentioned ethics committees and all subjects gave written
informed consent in accordance with the Declaration of Helsinki.
Data of the naïve repertoire of 10 HC’s and 15 CVID patients
were previously published (16). From this previous study we
excluded three CVID patients in which a (possible) genetic defect
has been identified. An overview of the included patients, B-cell
and T-cell subsets and antibody levels at diagnosis can be found
in Supplementary Table 1.
Repertoire Sequencing
Peripheral blood mononuclear cells (PBMCs) were isolated using
Ficoll. For naïve BCR repertoire DNA was isolated from sorted
naïve B-cells (CD27–, IgD+) using direct lysis (19). Next, 100
ng (or less when insufficient DNA was available) of DNA was
amplified using VH1-6 FR1 forward primers (BIOMED-2) and
JH consensus reverse primers (20). For analysis of the antigen
selected BCR repertoire mRNA was isolated from total PBMCs
using the Gen-Elute Mammalian total RNA miniprep kit from
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SigmaAldrich (St. Louis,MO). cDNAwas created from 2 ug RNA
[Superscript II reverse transcriptase kit Invitrogen (Paisley, UK)].
IGH transcripts were amplified in a multiplex PCR using forward
VH1-6 FR1 (BIOMED-2) primers and a CgCH1 or IGHA reverse
primer (20–22). All PCR products were purified and sequenced
using Roche 454 sequencing as previously described (23). In
short, PCR products were purified by gel extraction (Qiagen,
Valencia, CA) and Agencourt AMPure XP beads (Beckman
Coulter, Fullerton, CA). The PCR concentration was measured
using the Quant-it Picogreen dsDNA assay (Invitrogen, Carlsbad,
CA) and the purified PCR products were sequenced on the 454
GS junior instrument using the Lib-A or Lib-A V2 kits.
Immune Repertoire Data Analysis
Sequences were demultiplexed based on their multiplex identifier
sequence and trimmed from both sides (antigen selected BCR
repertoire: 40 nt; naïve BCR repertoire: 40 nt) (18). Fasta
files were uploaded in IMGT/High-V-Quest (version 1.5.6 for
the antigen selected BCR repertoire) (24), and subsequently
the IMGT output files were analyzed using ARGalaxy (18).
For analysis of the naïve BCR repertoire a single sequence
per clone (based on V gene, and CDR3 nucleotide sequence)
was selected for analysis. Replicates in which this resulted in
<100 sequences were excluded. For the antigen selected BCR
repertoire only sequences present two or more times (based
on CDR1-CDR3 nucleotide sequence) were included once in
the analysis. In addition, incomplete sequences or sequences
containing an ambiguous “n” base were excluded. Samples
containing a low number of reads for either IGHA or IGHG
after filtering (<45) or patients samples with increased clonal
relation as compared to HC’s (Supplementary Table 2) were
excluded. The age, presence of autoimmunity, and number
of sequences after filtering (Supplementary Table 2), and the
transition tables (Supplementary Table 3) can be found in the
Supplementary Information. To determine the selection strength
of the CDR and FR regions the BASELINe tool was used
(selection statistics: focused, SHM targeting model: human
Tri-nucleotide, custom boundaries: 25:26:38:55:65:104:-) (25,
26). Clonal relation between sequences was determined using
Change-O using the nucleotide hamming distance substitution
model with a complete distance of maximal three. For clonal
assignment the first genes were used, and the distances were
not normalized. In case of asymmetric distances, the minimal
distance was used (27).
Data Visualization and Statistics
Dot plots and statistics were performed using Graphpad Prism
V7.0. PCA analysis and heatmaps (heatmap2; gplots package)
were made using R.
RESULTS
To investigate whether CVID patients have alterations in
their BCR repertoire that might indicate defects in repertoire
formation or specification, we analyzed the naïve and the
antigen selected BCR in CVID patients and age-matched healthy
controls (HC’s). To analyse the naïve BCR repertoire we
sorted naïve B cells from 30 CVID patients and 16 HC’s and
amplified and sequenced the IGH gene. We performed 4–6
replicate PCR’s which allowed us to determine the number
of unique rearrangements that overlap between independent
PCRs from the same individual (co-incidences) and calculate
repertoire diversity (28). In two patients the BCR encoding
region could not be amplified, probably due to low DNA levels,
and these were excluded. For one patient only two replicates
resulted in >100 reads and this patient was excluded for
the calculation of repertoire diversity (Supplementary Table 2).
To analyse the antigen selected repertoire, we amplified and
sequenced IGHG and IGHA transcripts from peripheral blood
mononuclear cells PBMCs from 22 CVID patients including
11 patients of which we also analyzed the naïve repertoire.
Results were compared to previously obtained aged-matched
HC’s (29) From 18 patients >45 unique reads from IGHG
and/or IGHA transcripts were obtained. IGHA and/or IGHG
data from five patients were excluded based on increased clonal
relation of the data (Supplementary Table 2) (27). In total the
antigen selected repertoire of 16 patients was analyzed [IGHG
and IGHA (n = 9); IGHG only n = 6 and IGHA only n = 1;
Supplementary Table 2].
Some CVID Patients Have Reduced
Diversity of the Naïve BCR Repertoire and
Small Alterations in the Junctional Regions
To determine if individual CVID patients have a possible
defect in immune repertoire formation [V(D)J recombination]
we analyzed repertoire diversity and junction characteristics in
sorted naïve B-cells. In the HC’s we found that the diversity of
the naïve BCR repertoire decreases with age (Figure 1A). For
the majority of CVID patients, the naïve repertoire diversity was
within the 90% prediction bands of the HC’s. However, for three
patients the diversity was below the lower 90% prediction band
and for one patient below the 95% prediction band. Surprisingly,
one patient had a diversity above the upper 95% prediction
band (Figure 1A). In the junctions of the CVID patients we
found normal numbers of N-nucleotides and deletions in the
unproductive IGH rearrangements in all except for one patient
in which the number of N-nucleotides was marginally increased
(CVID33, Figure 1B). Unproductive rearrangements reflect the
rearrangements formed during V(D)J recombination that are not
expressed and therefore not selected.
In the productive IGH rearrangements the number of N-
nucleotides was above the normal range in 10 CVID patients.
Although this increase was minor, it was often associated
with a longer CDR3 length (Figures 1B,C). In addition, three
patients had a reduced number of deletions in their productive
rearrangements. In all except one (CVID33) patient, these
minor alterations in the junctions of productive rearrangements
were not associated with alterations in the junctions of
unproductive rearrangements and therefore it is unlikely the
result of defects during V(D)J recombination. Interestingly,
in three patients these alterations in the productive junctions
did coincide with reduced BCR repertoire diversity (CVID 14,
CVID24 CVID29).
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FIGURE 1 | Repertoire diversity and junction characteristics in CVID patients. (A) Repertoire diversity in HC’s (black) and CVID patients (red). A trendline representing
the correlation between age and repertoire diversity in HC’s is added. The dotted lines represent the 90 and 95% prediction bands based on the HC population.
(B) The number of N-nucleotides and deletions in the junctions of productive and unproductive rearrangements from HC’s and CVID patients and (C) the median
CDR3 length in productive rearrangements. The dotted lines represent the mean ±2 standard deviations (st dev) of the HC. (D) Heatmap showing the junction
characteristics of each patient. Values below 2 st dev from the mean of the HC samples are indicating by orange, while larger deviations from the mean are indicated
by darker shades of red. Values above 2 st dev from the mean are indicated with green with darker green representing increased deviation from the HC population.
Patients were clustered based on junction characteristics. Patients with a reduced or increased repertoire diversity are indicated by arrows (One arrow: within the
90–95% prediction bands; two arrows: outside of the 95% prediction bands). Statistical significance is performed using a Mann Whitney-test and indicated using *P <
0.05, **P < 0.01 and ****P < 0.0001.
Based on these data, we concluded that our cohort does not
include CVID patients with major defects in the processing phase
of V(D)J recombination. However, the patients with reduced
naïve repertoire diversity might have a mild defect in initiation
of V(D)J recombination or a different defect in precursor B-cell
development. The alterations in the junctions of the productive
rearrangements could indicate minor disturbances in B-cell
development downstream of the V(D)J recombination process.
Minor Skewing in SHM Patterns in CVID
Patients
To investigate if there are CVID patients in our cohort with a
defect in the molecular mechanism of SHM we analyzed the
percentage of mutations in AID (RGYW/WRCY) and pol eta
(WA/TW) motifs (Figures 2A–C), the percentage of mutations
at GC location (Figure 2D), and the percentage of transition
mutations at GC (Figure 2E) or A/T locations (Figure 2F).
We found that seven patients have normal SHM patterns,
suggesting a normal distribution between the repair pathways
(Figure 2G). In four patients, minor skewing was observed in
one subclass, but the same skewing could not be found in the
other subclass making a defect in the molecular mechanism of
SHM unlikely (CVID11, CVID12, CVID14, CVID18). CVID13
had skewing that could match reduced efficiency of MMR. Of
the remaining four patients three had increased transitions at AT
locations (CVID7, CVID15, and CVID17) and one patient had
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FIGURE 2 | Minor skewing in SHM patterns are found in a subgroup of CVID patients. (A) A schematic overview of the different pathways by which AID induced U
lesions can be repaired and the mutation patterns they are linked to. The percentages of mutations located in RGYW/WRCY (B) and TW/WA (C) motives in IGHA and
IGHG rearrangements of HC’s and CVID patients. (D) Percentage of mutations located at G/C locations. The percentage of mutations located at G/C (E) or A/T (F)
locations that are transitions. The dotted lines represent the mean ±2 standard deviations (st dev) of the HC. (G) Heatmap showing the different aspects of SHM
patterns per patient. Values <2 st dev below the mean are depicted in increasingly darker shades of red, while values >2 st dev above the mean are depicted in
increasingly darker shades of green. Patients (except CVID6) are clustered based on all data included in the heatmap. Dotted lines in graphs B-F represent the mean
plus and minus 2 st dev of the HC. Statistical significance is performed using a Mann Whitney-test and indicated using *P < 0.05 and **P < 0.001.
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FIGURE 3 | CVID patients often have reduced levels of SHM and reduced usage of more distal constant domains. (A) Median SHM levels in IGHG and IGHA
transcripts from HC’s and CVID patients. The dotted line indicates the mean ±2 st dev of the control samples. Statistical significance is performed using a Mann
Whitney-test and indicated using *P < 0.05 and **P < 0.01. (B) Schematic overview of the IGH locus and subclass distribution in IGHA and IGHG transcripts of CVID
patients and aged matched HC’s. (C) Heatmap showing the levels of SHM and subclass distribution in each patient. Patients who deviate more than 2 st dev from the
mean are depicted in increasingly darker shades of green (increased levels) or red (decreased levels). Patients (except CVID6) are clustered based on all heatmap data.
increased mutations at CG locations and increased transitions
at GC locations (CVID16). On a population basis, these minor
alterations lead to reduced pol eta targeting, increased mutations
at GC locations, and decreased number of transitions at A/T
locations in IGHG transcripts of CVID patients. Interestingly,
no significant skewing was found in IGHA transcripts. Together
these data indicate that the majority of patients do not have a
defect in the molecular mechanism of SHM. Some slight skewing
in SHM patterns were found in some patients which could
indicate minor defects in pathways involved in SHM. However,
these defects are unlikely to be disease causing in these patients.
The Majority of CVID Patients Have
Reduced SHM Levels and/or Reduced
Usage of Distal Constant Domains
It has been shown that a subgroup of CVID patients has
a defect in the GC (7). Since SHM and CSR take place in
the GC, we used these parameters to identify patients with
a possible GC defect. Our results show that eight out of 16
CVID patients have reduced SHM frequency in IGHG and/or
IGHA rearrangements (Figure 3A) leading to a significant
decrease in SHM levels in CVID patients as compared to
HC’s. Strikingly, the distribution of the IGHG subclasses was
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FIGURE 4 | CVID patients show minor alterations in GC selection. The R/S ratio (A) and selection strength as analyzed by BASELINe (B) in the FR region of IGHA and
IGHG transcripts. (C) The R/S ratio in the CDR regions of IGHA and IGHG transcripts. (D) The BASELINe selection strength in the CDR regions. Dotted lines in graphs
(A–D) represent the mean plus and minus 2 st dev. Statistical significance is performed using a Mann Whitney-test and indicated using ***P < 0.0005. (E) Heatmap
representing all outcomes for antigen selection per patient. Values below 2 st dev from the mean of the HC samples are indicating by orange, while larger deviations
from the mean are indicated by darker shades of red. Values above 2 st dev from the mean are indicated with green with darker green representing increased
deviation from the HC population. Patients are clustered based on all antigen selection parameters included.
altered in 13 of the 15 patients in whom IGHG transcripts
were analyzed (Figure 3B). In these patients the frequency
of IGHG2 transcripts was reduced while the frequencies
of IGHG3 or IGHG1 transcripts were often increased. The
subclass distribution of IGHA transcripts was abnormal in
three patients. Reduced SHM frequency always coincided
with altered subclass distribution (Figure 3C). Together these
data show that the majority of our CVID patients have
reduced SHM and altered subclass distribution which might
be indicative of a defect in the GC, or alternatively B-cell
activation.
CVID Patients Show Minor Alterations in
GC Selection
Next to SHM and CSR a third process taking place in the GC is
antigen selection. CVID patients have an impaired vaccination
response, which could be the effect of poor antigen selection
and affinity maturation. A hallmark of antigen selection is
an increased frequency of replacement (R) mutations relative
to silent mutations (S) in the complementary determining
region (CDR; R/S ratio). In contrast, the R/S ratio in the
framework region (FR) is low as R mutations in the FR can
cause BCR instability. In addition, we used Bayesian estimation
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FIGURE 5 | CVID patients have increased VH4-34 and JH6 usage and an increased CDR3 length. Mean CDR3 length (A) the percentage JH6 (B) and VH4-34 usage
(C), in naïve B-cells and IGHA and IGHG transcripts of antigen selected B-cells in all samples or samples of which paired data was available (D–F). The dotted lines in
(A–C) represent the mean ± the st dev of the controls. (G) Heatmap showing VH4-34 and JH6 usage and median CDR3 length for all patients. Values >2 st dev
below the mean are depicted in increasingly darker shades or red, while values >2 st dev above the mean are depicted in increasingly darker shades of green.
Patients are clustered based on the data included in the heatmap. CVID patients with autoimmunity are indicated in blue. Statistical significance is performed using a
Mann Whitney-test and indicated using *P < 0.05, **P < 0.01 and ***P < 0.001.
of Antigen-driven SELectIoN (BASELINe) to calculate antigen
selection in the CDR and FR regions (30).
In HC’s both the R/S ratio and the BASELINe selection
strength in the FR regions of IGHG and IGHA transcripts is
stable [Figures 4A,B; (29)]. One CVID patient shows reduced
antigen selection in the FR regions of IGHG rearrangements
according to BASELINe, however this finding was not confirmed
by an altered R/S ratio or alterations in the selection of IGHA
transcripts. When analyzing the selection in the CDR regions,
we found a reduced R/S ratio in the IGHG transcripts of four
patients, while the BASELINe selection strength was reduced
in one CVID patient (Figures 4C,D). However, these findings
did not coincide (Figure 4E), suggesting that none of the CVID
patients have major defects in antigen selection. Surprisingly,
at the cohort level we found a significant reduced R/S ratio in
the CDR of IGHG rearrangements of CVID patients. Together
this suggests that although almost all of the CVID patients
seem to have a defect in the GC, antigen selection was not
impaired in the IGHG or IGHA transcripts of individual
patients.
CVID Patients Show Reduced Selection
Against Repertoire Features Associated
With Auto-Immunity
Besides antigen selection, there is strong selection against features
associated with auto-immunity in both the bone marrow and
the GC. These features include a long CDR3 length and
the usage of the intrinsically auto-reactive IGHV4-34 gene
(29, 31). In the naïve BCR repertoire we found a marginal
increase in CDR3 length in seven CVID patients (Figure 5A),
which coincided with increased JH6 usage (the longest JH
gene) in three patients (Figure 5B). In nine patients, the
percentage of rearrangements using the IGHV4-34 gene was
increased which was associated with auto-immunity in two
patients (CVID27, CVID29; indicated in blue) (Figure 5C).
The total group of CVID patients has a significant increase
in CDR3 length and increased IGHV4-34 gene usage in their
naïve BCR repertoire as compared to HC’s (Figures 5A,B).
In the antigen selected BCR repertoire, the CDR3 length
of the IGHG and IGHA transcripts is shorter compared
to the naïve B cells in both the HC’s and CVID patients.
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FIGURE 6 | Minor alterations in the naïve BCR repertoire in a subgroup of CVID patients and alterations in the antigen selected IGHG repertoire in the majority of CVID
patients. (A) PCA analysis of CVID patients and HC’s based on all data extracted from the naïve BCR repertoire. (B) PCA analysis based on the antigen selected BCR
repertoire of HC’s and CVID patients. (C) Figure summarizing the processes during repertoire formation and specification that are disturbed in CVID patients.
However, in CVID patients the IGHG and the IGHA transcripts
have a longer CDR3 compared to the HC’s. We found
one CVID patient with a minor increase in median CDR3
length in IGHG transcripts (CVID4) and two patients with
increased JH6 usage (CVID10, CVID 11) (Figures 5A,B). More
pronounced differences were found in the IGHV4-34 gene
usage in CVID patients (Figures 5C,G) which showed increased
usage of VH4-34 in IGHG but not IGHA transcripts of
seven patients. However, again these auto-immune features
were not associated with clinical auto-immunity in these
patients.
CVID Patients Have Only Minor Alterations
in the Naïve BCR Repertoire, While Major
Skewing Is Found in the Antigen Selected
BCR Repertoire
We investigated if alterations found in the naïve BCR repertoire
of CVID patients (Figures 1, 5) coincided in the same patients.
Therefore, we created a heatmap representing all data presented
above (Supplementary Figure 1). Data shows that 12 CVID
patients have a completely normal naïve BCR repertoire while
in the remaining 16 patients, minor alterations in the diversity,
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junctions or auto-immune features were identified. Since all
differences found in the naïve BCR repertoire are minor,
principal component analysis (PCA) showed the majority of
CVID patients clustering together with the HC’s (Figure 6A;
Supplementary Figure 2A).
In the antigen selected BCR repertoire more pronounced
differences were found (Supplementary Figure 3). Only in two
patients (CVID5 and CVID6) all parameters investigated were
normal, and in both these patients also no differences were
found in the naïve BCR repertoire. In the remaining 14
patients, we mainly found differences in SHM levels and subclass
distribution (Supplementary Figure 3). The differences in the
antigen selected repertoire is further visualized when performing
PCA analysis based on all parameters analyzed in the IGHG
transcripts (Figure 6B; Supplementary Figure 2B). As expected
CVID5 clusters in between the controls (CVID6 is not included
due to missing IGHG data) but all other patients cluster away
from the controls to some extent indicating that IGHG repertoire
of CVID patients is often altered in CVID patients.
DISCUSSION
CVID patients have a defect in antibody production often
associated with a block or defect in B-cell development, but
the stage or process effected varies. Here we investigated
whether CVID patients have a defect in repertoire formation
or specification by analyzing the naïve and antigen selected
BCR repertoire. We mainly focused on deviating parameters
in individual patients to identify disease causing or disease
associated processes for individual patients instead of comparing
CVID patients to HCs as done in previous studies (16, 17, 32, 33).
Using a patient-based approach we identified the GC response
as the process in B-cell development that is most often affected
in CVID. In the large majority of patients (n = 13) we find less
usage of the distal constant domains which in eight patients is
associated with a reduced level of SHM described before (17,
32, 34, 35). Earlier studies have already found reduced numbers
of memory B-cells and/or plasmablasts in CVID suggesting a
quantitative defect in B cell development in the GC (7, 14). We
now show that in addition CVID patients have a qualitative defect
in the cells exiting the GC. It would be interesting to further
study the exact defect in the GC however, therefore it would
be necessary to look in the secondary lymphoid organs of these
patients and such material is rare.
We also looked in more detail at the patterns of SHM and
identified five patients with minor alterations in their SHM
patterns of which one would match a minor impairment in
MMR. This is in line with earlier findings of Duvvuri et al. which
found minor alterations in SHM patterns in some CVID patients
and more extensive skewing in line with a MMR defect in one
patient (33). The differences observed in our cohort are minor
and unlikely to be the disease causing.
When analyzing markers indicative for antigen selection in
IGHG and IGHA transcripts we did not observe any major
deviation. In contrast, when analyzing selection against features
associated with auto-immunity (IGHV4-34, CDR3 length, JH6
usage) we observed patients with increased auto-immune
features in both the naïve and antigen selected repertoire.
Most pronounced was the increased usage of IGHV4-34 in the
naïve repertoire and IGHG transcripts. However, when studying
the relation between the auto-immune repertoire features and
clinical presentation we did not find a clear correlation. In part
this might be explained by the fact that these repertoire features
are associated with auto-immunity but are not causative. In
addition, it might be that a subgroup of patients with increased
auto-immune features will develop auto-immunity at a later time
point.
When analyzing the naïve repertoire we found some
patients with minor alterations which could be indicative of
defects in early B-cell development or the initiation of V(D)J
recombination. This is in line with our previous study on a
subgroup of our cohort in which we found that the naïve
repertoire is normal in the majority of CVID patients (16). In
the present study we found a reduced repertoire diversity in four
of the 27 CVID patients and minor alterations in the junctions
(of productive sequences) in 11 patients. Importantly, we noticed
that the diversity of the naïve BCR repertoire decreases with age
in both the CVID patients and HC’s (Figure 1A). It is therefore
crucial that age-matched controls are used for the analysis of
repertoire diversity. Roskin et al. have previously shown that on a
population basis the diversity of the BCR repertoire was reduced
in CVID patients. Unfortunately, in their analysis age was not
taken into account making it difficult to identify if they also find
individual patients with a reduced repertoire diversity in their
cohort (17).
Although we find some alterations in the immune repertoire
of almost all patients, in two patients the repertoire was
completely normal (CVID5 and CVID6). This suggests that in
these patients no qualitative defect is found in BCR repertoire
formation or specification. Interestingly both patients were
included in the study of Driessen et al. in which they were both
categorized as CVID pattern 5 (7). This pattern identifies patients
with impaired antibody production by plasma cells which is in
line with our current findings.
In conclusion, in this study we analyzed the naïve and the
antigen selected BCR repertoire in CVID patients to pinpoint
the stage or process of B-cell development impaired in individual
patients. By comparing the results of individual patients to HC’s
we were able to identify the GC reaction as the process most
often deregulated in CVID patients. In addition, some patients
have possible defects in early B-cell development or selection
against auto-immune features. Together this indicates that in
CVID, repertoire formation is intact in the majority of patients,
while repertoire specification is often impaired (Figure 6C). This
further highlights that CVID patients not only have a quantitative
defect in B cell development, but that also the quality of B cells in
these patients is impaired.
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